Skip to main content
Earnings Labs
Rigel Pharmaceuticals, Inc. logo

Rigel Pharmaceuticals, Inc. (RIGL)

NASDAQ·Healthcare·Biotechnology

$33.34

+2.96%

Mkt Cap $607.79M

Analyst Ratings

Buy

5

Hold

0

Sell

0

Price Target (4 analysts)

$27.33

Range $2.00$42.00

Implied Upside

-18.0%

Consensus $27.33 vs current $33.34